FoLix (Fractional Laser for Hair)
World's first FDA-cleared fractional laser for hair loss treatment
이 치료에 대해
FoLix by Lumenis is the world's first and only FDA-cleared fractional laser specifically for hair loss treatment. Non-ablative 1064nm Nd:YAG creates microscopic thermal zones (MTZs) to activate natural follicular healing.
Winner of 2025 MedTech Breakthrough "Best New Dermatology Technology Solution" and NewBeauty "Best Laser Treatment for Hair Loss." A new option for patients resistant to medications or as PRP adjunct.
작용 기전
1064nm non-ablative fractional laser creates MTZs on the scalp, stimulating stem cells in the follicular bulge region and activating Wnt signaling pathway. Inflammatory cascade releases growth factors (VEGF, FGF, IGF-1), reversing follicular miniaturization and transitioning resting follicles to active growth phase.
적응증
기대 효과
Hair density increase confirmed after 4-6 sessions. Peak results 3-6 months after final treatment. Most effective for early-to-mid stage hair loss. Enhanced with medication and PRP combination. Maintenance 2-3x/year recommended.
임상 근거
위험 및 부작용
Mild discomfort during treatment (manageable with topical anesthesia). Transient scalp redness (hours). Minimal downtime. Limited efficacy for advanced hair loss with complete follicle loss.